UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19

European journal of clinical pharmacology, 2021-09, Vol.77 (9), p.1275-1293

2021

Volltextzugriff (PDF)

Correction to: Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19

European journal of clinical pharmacology, 2021-09, Vol.77 (9), p.1295-1295

2021

Volltextzugriff (PDF)

Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?

Retrovirology, 2012-09, Vol.9 (1), p.72-72, Article 72

2012

Volltextzugriff (PDF)

Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines

Molecular therapy, 2013-01, Vol.21 (1), p.251-259

2013

Volltextzugriff (PDF)

Human T-lymphotropic virus 1: recent knowledge about an ancient infection

The Lancet infectious diseases, 2007-04, Vol.7 (4), p.266-281

2007

Volltextzugriff (PDF)

Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection

AIDS (London), 2018-11, Vol.32 (17), p.2533-2545

2018

Volltextzugriff (PDF)

A call for strengthened evidence on targeted, non-pharmaceutical interventions against COVID-19 for the protection of vulnerable individuals in sub-Saharan Africa

International journal of infectious diseases, 2020-10, Vol.99, p.482-484

2020

Volltextzugriff (PDF)

Can immunotherapy be useful for a « functional cure » of HIV infection?

Retrovirology, 2011-10, Vol.8 (S2), p.O33-O33, Article O33

Vanham, Guido

2011

Volltextzugriff (PDF)

Evolutionary Dynamics and Complicated Genetic Transmission Network Patterns of HIV-1 CRF01_AE among MSM in Shanghai, China

Scientific reports, 2016-10, Vol.6 (1), p.34729, Article 34729

2016

Volltextzugriff (PDF)

Effectiveness of COVID-19 primary and booster vaccination in HIV-infected individuals

AIDS (London), 2023-04, Vol.37 (5), p.837-839

2023

Volltextzugriff (PDF)

Cytotoxic CD8+ T Cells Expressing CXCR5 Are Detectable in HIV-1 Elite Controllers After Prolonged In Vitro Peptide Stimulation

Frontiers in immunology, 2021-02, Vol.11, p.622343-622343

2021

Volltextzugriff (PDF)

Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy Caucasian women

PloS one, 2012-08, Vol.7 (8), p.e43951-e43951

2012

Volltextzugriff (PDF)

The N276 glycosylation site is required for HIV-1 neutralization by the CD4 binding site specific HJ16 monoclonal antibody

PloS one, 2013-07, Vol.8 (7), p.e68863

2013

Volltextzugriff (PDF)

Visualization of X4- and R5-Tropic HIV-1 Viruses Expressing Fluorescent Proteins in Human Endometrial Cells: Application to Tropism Study

PloS one, 2017-01, Vol.12 (1), p.e0169453-e0169453

2017

Volltextzugriff (PDF)

Evidence that HIV-1 CRF01_AE is associated with low CD4+T cell count and CXCR4 co-receptor usage in recently infected young men who have sex with men (MSM) in Shanghai, China

PloS one, 2014-02, Vol.9 (2), p.e89462-e89462

2014

Volltextzugriff (PDF)

Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients

PloS one, 2012-05, Vol.7 (5), p.e37792-e37792

2012

Volltextzugriff (PDF)

iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

Trials, 2019-06, Vol.20 (1), p.361-361, Article 361

2019

Volltextzugriff (PDF)

Development and in Vitro Evaluation of a Microbicide Gel Formulation for a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family

Journal of medicinal chemistry, 2016-03, Vol.59 (6), p.2747-2759

2016

Volltextzugriff (PDF)

Leveraging T-cell receptor - epitope recognition models to disentangle unique and cross-reactive T-cell response to SARS-CoV-2 during COVID-19 progression/resolution

Frontiers in immunology, 2023, Vol.14, p.1130876-1130876

2023

Volltextzugriff (PDF)

Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients

Frontiers in immunology, 2018-01, Vol.8, p.1943-1943

2018

Volltextzugriff (PDF)

Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors

Journal of Virology, 2007-06, Vol.81 (12), p.6548-6562

2007

Volltextzugriff (PDF)

The Replicative Fitness of Primary Human Immunodeficiency Virus Type 1 (HIV-1) Group M, HIV-1 Group O, and HIV-2 Isolates

Journal of Virology, 2005-07, Vol.79 (14), p.8979-8990

2005

Volltextzugriff (PDF)

Efficient Induction of Antigen-Specific CD8+ T-Cell Responses by Cationic Peptide-Based mRNA Nanoparticles

Pharmaceutics, 2022-06, Vol.14 (7), p.1387

2022

Volltextzugriff (PDF)

1 – 25 von 208

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(202)
Mit Volltextzugriff
(186)

Publikationsform

Sprache

Englisch
(207)
Ukrainisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19

Correction to: Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19

Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?

Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines

Human T-lymphotropic virus 1: recent knowledge about an ancient infection

Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection

The COVID-19 pandemic: diverse contexts; different epidemics—how and why?

A call for strengthened evidence on targeted, non-pharmaceutical interventions against COVID-19 for the protection of vulnerable individuals in sub-Saharan Africa

Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe

Can immunotherapy be useful for a « functional cure » of HIV infection?

Evolutionary Dynamics and Complicated Genetic Transmission Network Patterns of HIV-1 CRF01_AE among MSM in Shanghai, China

Effectiveness of COVID-19 primary and booster vaccination in HIV-infected individuals

Cytotoxic CD8+ T Cells Expressing CXCR5 Are Detectable in HIV-1 Elite Controllers After Prolonged In Vitro Peptide Stimulation

Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy Caucasian women

The N276 glycosylation site is required for HIV-1 neutralization by the CD4 binding site specific HJ16 monoclonal antibody

Visualization of X4- and R5-Tropic HIV-1 Viruses Expressing Fluorescent Proteins in Human Endometrial Cells: Application to Tropism Study

Evidence that HIV-1 CRF01_AE is associated with low CD4+T cell count and CXCR4 co-receptor usage in recently infected young men who have sex with men (MSM) in Shanghai, China

Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients

iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

Development and in Vitro Evaluation of a Microbicide Gel Formulation for a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family

Leveraging T-cell receptor - epitope recognition models to disentangle unique and cross-reactive T-cell response to SARS-CoV-2 during COVID-19 progression/resolution

Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients

Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors

The Replicative Fitness of Primary Human Immunodeficiency Virus Type 1 (HIV-1) Group M, HIV-1 Group O, and HIV-2 Isolates

Efficient Induction of Antigen-Specific CD8+ T-Cell Responses by Cationic Peptide-Based mRNA Nanoparticles

Suchergebnisse filtern